cilostazol (Preferred Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the cilostazol drug offered from Preferred Pharmaceuticals, Inc.. This Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Preferred Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | cilostazol |
SUBSTANCE NAME: | CILOSTAZOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-07-28 |
END MARKETING DATE: | 0000-00-00 |
cilostazol HUMAN PRESCRIPTION DRUG Details:
Item Description | cilostazol from Preferred Pharmaceuticals, Inc. |
LABELER NAME: | Preferred Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2014-07-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68788-9380_9c6ad60b-3cb3-4a62-bad1-9c7e29f4c94a |
PRODUCT NDC: | 68788-9380 |
APPLICATION NUMBER: | ANDA077030 |
Other CILOSTAZOL Pharmaceutical Manufacturers / Labelers: